Company intelligence / Profile preview
Dermoaroma
Rome, Lazio, Italydermoaroma.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Dermoaroma's proprietary AMPLEX Plus platform leverages secretomes, growth factors, and exosomes derived from organic bovine colostrum for regenerative skin therapies. Clinical results support effectiveness in skin rejuvenation, accelerated healing, and improved collagen synthesis, evidenced by 14 scientific patents and broad adoption among aesthetic practitioners in 60 countries[1][2][4].
- Therapeutic areas
- Dermatology
- Modalities
- Exosome-based therapyGrowth factor therapySecretome therapyPlatelet-rich plasmaMedical deviceSmall molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Dermoaroma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermoaroma.